Ubs Asset Management Americas Inc Epizyme, Inc. Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.42 - $1.48 $76,563 - $269,793	-182,293 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.06 - $2.68 $85,864 - $217,090	81,004 Added 79.97%	182,293 $209,000
Q2 2021 Aug 16, 2021	BUY	$6.81 - $9.71 $144,167 - $205,560	21,170 Added 26.42%	101,289 $841,000
Q1 2021 May 14, 2021	BUY	$7.45 - $12.32 $66,319 - $109,672	8,902 Added 12.5%	80,119 $697,000
Q4 2020 Mar 01, 2021	BUY	$10.34 - $13.77 $83,898 - $111,729	8,114 Added 12.86%	71,217 $773,000
Q3 2020 Nov 13, 2020	SELL	$11.73 - $16.25 $68,714 - $95,192	-5,858 Reduced 8.49%	63,103 $752,000
Q2 2020 Aug 14, 2020	BUY	$13.68 - $20.46 $63,529 - $95,016	4,644 Added 7.22%	68,961 $1.11 Million
Q1 2020 May 15, 2020	SELL	$14.83 - $26.72 $79,622 - $143,459	-5,369 Reduced 7.7%	64,317 $997,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $24.6 $80,436 - $202,531	8,233 Added 13.4%	69,686 $1.71 Million
Q3 2019 Nov 14, 2019	BUY	$10.17 - $13.86 $167,988 - $228,939	16,518 Added 36.76%	61,453 $634,000
Q2 2019 Aug 15, 2019	BUY	$11.43 - $15.12 $39,673 - $52,481	3,471 Added 8.37%	44,935 $0
Q1 2019 May 14, 2019	BUY	$5.98 - $13.98 $28,895 - $67,551	4,832 Added 13.19%	41,464 $0
Q4 2018 Feb 13, 2019	BUY	$5.22 - $10.44 $87,863 - $175,726	16,832 Added 85.01%	36,632 $225,000
Q1 2018 May 14, 2018	BUY	$12.5 - $19.75 $120,000 - $189,600	9,600 Added 94.12%	19,800 $0
Q3 2017 Nov 13, 2017	BUY	$12.7 - $19.25 $129,540 - $196,350	10,200	10,200 $0

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.